Action signal — 🔍 Research

Surfaced by the 2026-10-09 actions digest.

Action: 🔍 Research (LOW) RSI: 20.5

Why this is in actions

Lost its 200-day this week (above it last edition): a strong year now under test. The September 23 IMVT-1402 cutaneous-lupus miss (company release) is history; this week's leg has no dated item (news pulled October 3, no stock event, no October 9 capture). Clinical-stage veto

Trade Summary

Stub — 🔍 Research means more research needed before action.

Sources

• Actions digest: 2026-10-09-actions-daily-digest
• Original row: | **IMVT** | $30.47 | reclaim of the 200-day ($31.86) | 20.5 | **-21.37%** | 74.31% | -4.4% | 2026-10-09 | biotech-scan, monster-scan (Secular) | 🔍 Research | Lost its 200-day this week (above it las
• Price truth: summaries